JP2002538132A5 - - Google Patents

Download PDF

Info

Publication number
JP2002538132A5
JP2002538132A5 JP2000602198A JP2000602198A JP2002538132A5 JP 2002538132 A5 JP2002538132 A5 JP 2002538132A5 JP 2000602198 A JP2000602198 A JP 2000602198A JP 2000602198 A JP2000602198 A JP 2000602198A JP 2002538132 A5 JP2002538132 A5 JP 2002538132A5
Authority
JP
Japan
Prior art keywords
group
substituted
halogen
salt
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000602198A
Other languages
English (en)
Japanese (ja)
Other versions
JP4089159B2 (ja
JP2002538132A (ja
Filing date
Publication date
Priority claimed from AUPP8912A external-priority patent/AUPP891299A0/en
Application filed filed Critical
Publication of JP2002538132A publication Critical patent/JP2002538132A/ja
Publication of JP2002538132A5 publication Critical patent/JP2002538132A5/ja
Application granted granted Critical
Publication of JP4089159B2 publication Critical patent/JP4089159B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000602198A 1999-02-26 2000-02-03 コリン作用活性の強化作用を有するアミド化合物 Expired - Fee Related JP4089159B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU8912 1994-10-19
AUPP8912A AUPP891299A0 (en) 1999-02-26 1999-02-26 New 6-membered cyclic compounds
PCT/JP2000/000601 WO2000051970A1 (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity

Publications (3)

Publication Number Publication Date
JP2002538132A JP2002538132A (ja) 2002-11-12
JP2002538132A5 true JP2002538132A5 (enExample) 2005-07-07
JP4089159B2 JP4089159B2 (ja) 2008-05-28

Family

ID=3813111

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000602198A Expired - Fee Related JP4089159B2 (ja) 1999-02-26 2000-02-03 コリン作用活性の強化作用を有するアミド化合物

Country Status (19)

Country Link
EP (1) EP1159258B1 (enExample)
JP (1) JP4089159B2 (enExample)
KR (1) KR100620406B1 (enExample)
CN (1) CN1170814C (enExample)
AR (1) AR029618A1 (enExample)
AT (1) ATE282022T1 (enExample)
AU (2) AUPP891299A0 (enExample)
BR (1) BR0010225A (enExample)
CA (1) CA2371827C (enExample)
DE (1) DE60015732T2 (enExample)
DK (1) DK1159258T3 (enExample)
ES (1) ES2226775T3 (enExample)
HK (1) HK1044934B (enExample)
HU (1) HUP0200116A3 (enExample)
PT (1) PT1159258E (enExample)
RU (1) RU2211215C2 (enExample)
TR (1) TR200102494T2 (enExample)
TW (1) TWI225856B (enExample)
WO (1) WO2000051970A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5558648B2 (ja) 1998-11-23 2014-07-23 デイビス、ボニー アセチルコリンエステラーゼ阻害剤のための投与製剤
HUP0104778A3 (en) 1998-12-24 2004-05-28 Janssen Pharmaceutica Nv Controlled release galantamine composition
TWI241190B (en) 2001-02-13 2005-10-11 Aventis Pharma Gmbh 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
PE20020870A1 (es) 2001-02-13 2002-11-18 Aventis Pharma Gmbh 6,7,8,9-tetrahidro-5h-benzocicloheptenil aminas aciladas
PE20020856A1 (es) * 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
EP1506166B1 (en) * 2002-05-17 2011-11-16 Janssen Pharmaceutica NV Aminotetralin-derived urea modulators of vanilloid vr1 receptor
NZ545747A (en) 2003-08-06 2010-06-25 Senomyx Inc T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
EP2010009B1 (en) 2006-04-21 2017-06-14 Senomyx, Inc. Processes for preparing solid flavorant compositions
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AR075401A1 (es) 2009-02-13 2011-03-30 Sanofi Aventis Indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento
JP2025066196A (ja) * 2022-03-14 2025-04-23 国立大学法人東北大学 認知機能改善剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8287M (enExample) * 1968-12-31 1970-11-09
US4797419A (en) * 1986-11-03 1989-01-10 Warner-Lambert Company Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
EP0306375A1 (fr) * 1987-08-07 1989-03-08 Synthelabo Dérivés de[(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
CA1340113C (en) * 1988-05-24 1998-11-03 Magid A. Abou-Gharbia Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
GB8917687D0 (en) * 1989-08-02 1989-09-20 Fujisawa Pharmaceutical Co Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
RU2024507C1 (ru) * 1991-11-18 1994-12-15 Евгений Яковлевич Левитин 5-хлор-2-пиридиламид-4-нитро-n-(карбоксиметил)антраниловой кислоты, проявляющий противовоспалительную активность
JPH06107544A (ja) * 1992-09-29 1994-04-19 Taisho Pharmaceut Co Ltd コリン作動性神経不全の改善・治療薬
JPH06298732A (ja) * 1993-02-16 1994-10-25 Taisho Pharmaceut Co Ltd インドール誘導体

Similar Documents

Publication Publication Date Title
JP2002538132A5 (enExample)
JP2005511697A5 (enExample)
KR970703333A (ko) 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists)
CA2436980A1 (en) Amido ether substituted imidazoquinolines
JP2004002414A5 (enExample)
JP2001072695A5 (enExample)
CA2432572A1 (en) Oxybenzamides derivatives as factor xa inhibitors
JP2005538057A5 (enExample)
JPH10279578A5 (enExample)
KR870001196A (ko) 피리딘 화합물과 그의 제법 및 그를 함유하는 약학조성물
JPH1180090A5 (enExample)
JP2013542980A5 (enExample)
JP2002338936A5 (ja) 半導体ウエハ加工用粘着シートおよび半導体ウエハの加工方法
JP2005511545A5 (enExample)
JP2004532346A5 (enExample)
CA2526991A1 (en) Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
JP2003534359A5 (enExample)
JPH10287651A5 (enExample)
RU2001126120A (ru) Амидные соединения для усиления холинергической активности
JP2005511594A5 (enExample)
RU2004117595A (ru) Производные пиридина в качестве лигандов рецептора nmda
JP2003506455A5 (enExample)
CA2371827A1 (en) Amide compounds for the potentiation of cholinergic activity
JP2005511559A5 (enExample)
JP2002523496A5 (enExample)